{"id":"https://openalex.org/W2248747155","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.8531","title":"Final report: Combination of MPC-6827 with temozolomide for the treatment of patients with metastatic melanoma.","display_name":"Final report: Combination of MPC-6827 with temozolomide for the treatment of patients with metastatic melanoma.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2248747155","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.8531","mag":"2248747155"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.8531","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.8531","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.8531","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081309611","display_name":"W. Hwu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Hwu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016686763","display_name":"Wallace Akerley","orcid":"https://orcid.org/0000-0002-3090-4778","observed_orcids":["https://orcid.org/0000-0002-3090-4778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. L. Akerley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049728312","display_name":"John R. Stephenson","orcid":"https://orcid.org/0000-0002-7902-1837","observed_orcids":["https://orcid.org/0000-0002-7902-1837"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Stephenson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103094893","display_name":"Margaret K. Yu","orcid":"https://orcid.org/0009-0003-1697-3595","observed_orcids":["https://orcid.org/0009-0003-1697-3595","https://orcid.org/0000-0002-3650-2788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. K. Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"B. A. Evans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. A. Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038981531","display_name":"GARY G. MATHER","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Mather","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064099541","display_name":"Edward A. Swabb","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. A. Swabb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028592995","display_name":"Omid Hamid","orcid":"https://orcid.org/0000-0002-8238-4655","observed_orcids":["https://orcid.org/0000-0002-8238-4655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. Hamid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"8531","last_page":"8531"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.05939999967813492,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.7929999828338623},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/microtubule-destabilizing-agents","display_name":"microtubule destabilizing agents","score":0.921999990940094},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9169999957084656},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8500000238418579},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7599999904632568},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7250000238418579},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.6940000057220459},{"id":"https://openalex.org/keywords/stage-iv-melanoma","display_name":"stage IV melanoma","score":0.7360000014305115},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.4690000116825104},{"id":"https://openalex.org/keywords/cerebral-hemorrhage","display_name":"cerebral hemorrhage","score":0.6129999756813049},{"id":"https://openalex.org/keywords/troponin-i-elevation","display_name":"troponin I elevation","score":0.949999988079071},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.40299999713897705},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.30300000309944153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9660857915878296},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8572216033935547},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.7008057832717896},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5957068204879761},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.419086217880249},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.416476309299469},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4116500914096832},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4002811014652252},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3804563581943512},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3420620560646057},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3334271311759949},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.8531","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.8531","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.8531","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2330361544","https://openalex.org/W2248762046","https://openalex.org/W2114237537","https://openalex.org/W2507955117","https://openalex.org/W2068284159","https://openalex.org/W2090563514","https://openalex.org/W2274963722","https://openalex.org/W2044910169","https://openalex.org/W2028607345","https://openalex.org/W2285921731"],"abstract_inverted_index":{"8531":[0],"Background:":[1],"MPC-6827":[2,20,36,86,213],"(Azixa)":[3],"is":[4,268],"a":[5,31,79,94,193,223],"microtubule":[6],"destabilizing":[7],"agent.":[8],"This":[9],"study":[10],"was":[11,51,249],"designed":[12],"to":[13,288],"establish":[14],"the":[15,60,74,103,122],"safety":[16],"and":[17,91,105,206,230,261,270],"tolerability":[18],"of":[19,35,40,44,64,78,85,136,228],"when":[21],"combined":[22],"with":[23,30,146,265,280,299],"temozolomide.":[24],"Methods:":[25],"Patients":[26,100],"were":[27,87,110,119,127,154],"treated":[28],"weekly":[29],"2-hour":[32],"intravenous":[33],"infusion":[34],"for":[37],"either":[38,54],"6":[39,62],"8":[41,181,229],"or":[42,68,187,300,307,311],"3":[43,76,196],"4":[45,231],"consecutive":[46],"weeks":[47,63,77],"per":[48],"cycle.":[49,81,124],"Temozolomide":[50],"administered":[52],"orally":[53],"at":[55,69,112],"75":[56],"mg/m2":[57,71,107],"daily":[58,72],"during":[59,73,121],"first":[61,75,123],"an":[65,161],"8-week":[66],"cycle":[67],"85":[70],"4-week":[80,113],"Three":[82],"pre-selected":[83],"doses":[84],"tested:":[88],"2.1,":[89],"2.7,":[90],"3.3":[92,106],"mg/m2in":[93],"standard":[95],"\u201c3":[96],"+":[97],"3\u201d":[98],"design.":[99],"enrolled":[101],"in":[102,202,263,278,295],"2.7":[104],"dose":[108],"levels":[109],"studied":[111],"cycles.":[114],"Acute":[115],"dose-limiting":[116],"toxicities":[117],"(DLTs)":[118],"assessed":[120],"Pharmacokinetic":[125],"evaluations":[126],"performed.":[128],"Results:":[129],"All":[130],"patients":[131,140,157,167,172,182,190,221,238,264,279,298],"have":[132],"completed":[133],"study.":[134],"As":[135],"January":[137],"7,":[138],"2010,22":[139],"(age":[141],"range,":[142],"35-81;":[143],"17":[144],"male)":[145],"stage":[147],"IV":[148],"(3":[149],"M1b,":[150],"19":[151],"M1c)":[152],"melanoma":[153,267,297],"enrolled.":[155],"Twenty-one":[156],"(95":[158],"%)":[159],"had":[160,168],"ECOG":[162],"score":[163],"0-1.":[164],"Ten":[165],"(45%)":[166],"brain":[169,302],"metastases.":[170,282],"Twenty":[171],"received":[173,184],"prior":[174,185],"systemic":[175],"therapy":[176],"(median":[177],"2,":[178],"range":[179],"1-5);":[180],"(36%)":[183],"temozolomide":[186,262,291],"dacarbazine.":[188],"Two":[189,220],"(9%)":[191],"experienced":[192],"\u2265":[194],"grade":[195],"MPC-6827-related":[197],"SAE,":[198],"one":[199,207],"asymptomatic":[200],"elevation":[201],"Troponin":[203],"I":[204],"level":[205],"cerebral":[208],"hemorrhage":[209],"(a":[210],"DLT).":[211],"The":[212,246,258,283],"half-life":[214],"(t\u00bd)":[215],"ranged":[216],"from":[217],"2.9-10.6":[218],"hours.":[219],"achieved":[222,239],"confirmed":[224],"partial":[225],"response":[226],"(durations":[227],"months)":[232],"by":[233],"modified":[234],"RECIST.":[235],"Another":[236],"10":[237],"stable":[240],"disease":[241,274],"(duration":[242],"range:":[243],"1.5-7":[244],"months).":[245],"median":[247,284],"PFS":[248,285],"2.8":[250],"months":[251],"(95%":[252],"CI:":[253],"[1.7,":[254],"5.5":[255],"months]).":[256],"Conclusions:":[257],"combination":[259],"ofMPC-6827":[260],"metastatic":[266],"safe":[269],"well":[271],"tolerated.":[272],"Durable":[273],"controls":[275],"are":[276],"observed":[277],"refractory":[281],"compares":[286],"favorably":[287],"studies":[289],"using":[290],"as":[292],"first-line":[293],"treatment":[294],"chemotherapy-na\u00efve":[296],"without":[301],"metastasis.":[303],"Author":[304],"Disclosure":[305],"Employment":[306],"Leadership":[308],"Position":[309],"Consultant":[310],"Advisory":[312],"Role":[313],"Stock":[314],"Ownership":[315],"Honoraria":[316],"Research":[317],"Funding":[318],"Expert":[319],"Testimony":[320],"Other":[321],"Remuneration":[322],"Myriad":[323,326,329],"Pharmaceuticals,":[324,327,330],"Inc.":[325,328,331]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}